Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

BioNTech SE - American Depositary Shares (NQ:BNTX)

94.50 -2.77 (-2.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
67 68 Next >
BioNTech, Pfizer File For Clearance Over COVID-19 Vaccine Patent Dispute With CureVac
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock? 
Via Benzinga
WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years
Via Benzinga
Why BioNTech Is Trading Higher Today Following A Stock Upgrade From SVB Securities Analyst
SVB Securities, a division of SVB Financial Group (NASDAQ: SIVB), believes BioNTech SE – ADR (NASDAQ: BNTX) stock is trading below the most negative scenario for the COVID-19 vaccine mar 
Via Benzinga
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
5 Analysts Have This to Say About BioNTech
BioNTech (NASDAQ:BNTX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade
BioNTech won an upgrade Wednesday. Here's what one analyst expects to drive growth. 
Via Investor's Business Daily
AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, In Expert Review
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
Upgrades 
Via Benzinga
Benzinga Before The Bell: Most Effective Covid-19 Vaccine, Google's Hiring Slowdown, Panasonic's New EV Battery And Other Top Financial Stories Wednesday, July 13
CNBC Bankrupt Crypto Firm Three Arrows Capital’s Assets Frozen By New York Judge 
Via Benzinga
Amazon.com To $145? Here's The Biggest Price Target Changes For Wednesday
SVB Leerink cut BioNTech SE (NASDAQ: BNTX) price target from $253 to $223. BioNTech shares rose 2.1% to $164.77 in pre-market trading. 
Via Benzinga
Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out
Via Benzinga
U.S. Stock Futures Higher; All Eyes On Inflation Data
Pre-open movers 
Via Benzinga
The Good News For Moderna's Covid Shot Barely Moved Its Stock
Moderna stock reacted minimally to positive results for its updated Covid booster. 
Via Investor's Business Daily
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Novavax is hoping to launch an updated Covid booster shot. 
Via Investor's Business Daily
Pharma Rally Continues As Pfizer, Amgen Look To Break Out, Pulling Rivals With Them
Four pharmaceutical stocks, including three biotech movers, are making big moves. 
Via Investor's Business Daily
What Is Going on With Novavax (NVAX) Stock Today?
NVAX stock is down more than 8% today even after a surprise announcement of a vaccine deal with the U.S. government. 
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
Via Benzinga
US Government Signs COVID-19 Vaccine Pact With Novavax, With FDA Decision Still Pending
Novavax Inc (NASDAQ: NVAX) has announced an agreement with the U.S. 
Via Benzinga
Novavax, Moderna, BioNTech Surge To 3-Month High As Omicron Boosters Loom
Moderna and BioNTech also surged to a three-month high Friday. 
Via Investor's Business Daily
European Regulator Willing To Use COVID-19 Boosters Targeting Omicron Variants
At a press briefing, the European Medicines Agency (EMA) said it is open to using updated COVID-19 vaccines that target older omicron variants this Fall, amid a rise in cases due to new om 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Stocks Ready For A Bounce
The past few days have been volatile, but, stocks look ready for a bounce. Since the last CPI report, even energy stocks have fallen, pretty sharply in fact. 
Via Talk Markets
Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report
Via Benzinga
Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot
The company isn't seeking an injunction, but wants "fair compensation." 
Via Investor's Business Daily
Is Pfizer Stock A Buy Or A Sell As Its Covid Vaccine Faces A New Lawsuit?
The FDA's advisors recently backed Pfizer's Covid shot for young children. 
Via Investor's Business Daily
Is Moderna Stock A Buy As The Covid Battle With Pfizer Heats Up?
Moderna and Pfizer are likely to launch their Covid vaccines for babies at the same time. 
Via Investor's Business Daily
Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot
The company isn't seeking an injunction, but wants "fair compensation." 
Via Investor's Business Daily
CureVac Files COVID-19 Vaccine Patent Infringement Lawsuit Against BioNTech
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
67 68 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.